These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9055136

  • 1. Pharmacokinetics and effect of ticlopidine on platelet aggregation in subjects with normal and impaired renal function.
    Buur T, Larsson R, Berglund U, Donat F, Tronquet C.
    J Clin Pharmacol; 1997 Feb; 37(2):108-15. PubMed ID: 9055136
    [Abstract] [Full Text] [Related]

  • 2. Bioequivalence of two preparations of ticlopidine evaluated using a pharmacodynamic end point.
    Splawinski J, Kuzniar J, Kurianowicz R, Wanczura P.
    Int J Clin Pharmacol Ther; 2005 Sep; 43(9):452-6. PubMed ID: 16163899
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and the antiplatelet effect of a new clopidogrel formulation, clopidogrel besylate, in healthy subjects.
    Park JY, Kim KA, Ryu JH, Lee GH, Jeon SH, Kim JS.
    Int J Clin Pharmacol Ther; 2010 Apr; 48(4):259-69. PubMed ID: 20353747
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with severe renal impairment.
    Butler K, Teng R.
    J Clin Pharmacol; 2012 Sep; 52(9):1388-98. PubMed ID: 21960668
    [Abstract] [Full Text] [Related]

  • 5. Ticlopidine in China: comparative study on the effect of two dose levels on bleeding time and platelet function in healthy volunteers.
    Ruan C, Destelle G, Wang Z, Wan H, He Y, Cheng D, Li P, Duffas M.
    Haemostasis; 1989 Sep; 19(2):94-9. PubMed ID: 2731781
    [Abstract] [Full Text] [Related]

  • 6. Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration.
    DiPerri T, Pasini FL, Frigerio C, Blardi P, Centini F, Messa GL, Ghezzi A, Volpi L.
    Eur J Clin Pharmacol; 1991 Sep; 41(5):429-34. PubMed ID: 1761070
    [Abstract] [Full Text] [Related]

  • 7. Effects of ticlopidine or ticlopidine plus aspirin on platelet aggregation and ATP release in normal volunteers: why aspirin improves ticlopidine antiplatelet activity.
    Altman R, Scazziota A, Rouvier J, Gonzalez C.
    Clin Appl Thromb Hemost; 1999 Oct; 5(4):243-6. PubMed ID: 10726021
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and platelet aggregation inhibitory effects of a novel intravenous formulation of clopidogrel in humans.
    Cushing DJ, Souney PF, Cooper WD, Mosher GL, Adams MP, Machatha S, Zhang B, Kowey PR.
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):3-8. PubMed ID: 21933229
    [Abstract] [Full Text] [Related]

  • 9. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
    Sakata T, Kobayashi K, Katayama Y, Takada T, Matsuyama T.
    Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamics of ticlopidine: relation between dose and time of administration to platelet inhibition.
    Kuzniar J, Splawinska B, Malinga K, Mazurek AP, Splawinski J.
    Int J Clin Pharmacol Ther; 1996 Aug; 34(8):357-61. PubMed ID: 8864800
    [Abstract] [Full Text] [Related]

  • 11. Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.
    Karaźniewicz-Łada M, Danielak D, Burchardt P, Kruszyna L, Komosa A, Lesiak M, Główka F.
    Clin Pharmacokinet; 2014 Feb; 53(2):155-64. PubMed ID: 24127209
    [Abstract] [Full Text] [Related]

  • 12. Changes of rabbit platelet function on simultaneous administration of ticlopidine hydrochloride and OKY-046.
    Kosugi T, Nakamura M, Saitoh S, Kinjoh K.
    Int J Tissue React; 1991 Feb; 13(3):123-9. PubMed ID: 1960013
    [Abstract] [Full Text] [Related]

  • 13. Impact of common ABCB1 polymorphism on pharmacokinetics and pharmacodynamics of clopidogrel and its metabolites.
    Karaźniewicz-Łada M, Danielak D, Rubiś B, Burchardt P, Komosa A, Lesiak M, Główka F.
    J Clin Pharm Ther; 2015 Apr; 40(2):226-31. PubMed ID: 25430046
    [Abstract] [Full Text] [Related]

  • 14. Comparative pharmacokinetics/pharmacodynamics of clopidogrel besylate and clopidogrel bisulfate in healthy Korean subjects.
    Kim BH, Kim JR, Lim KS, Shin HS, Yoon SH, Cho JY, Jang IJ, Shin SG, Yu KS.
    Clin Drug Investig; 2012 Dec; 32(12):817-26. PubMed ID: 23026843
    [Abstract] [Full Text] [Related]

  • 15. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood.
    Heptinstall S, May JA, Glenn JR, Sanderson HM, Dickinson JP, Wilcox RG.
    Thromb Haemost; 1995 Nov; 74(5):1310-5. PubMed ID: 8607115
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of antiplatelet effects of ticlopidine in cats.
    Hogan DF, Andrews DA, Talbott KK, Green HW, Ward MP, Calloway BM.
    Am J Vet Res; 2004 Mar; 65(3):327-32. PubMed ID: 15027681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.